IL151667A0 - A METHOD OF PRODUCING IgG - Google Patents

A METHOD OF PRODUCING IgG

Info

Publication number
IL151667A0
IL151667A0 IL15166701A IL15166701A IL151667A0 IL 151667 A0 IL151667 A0 IL 151667A0 IL 15166701 A IL15166701 A IL 15166701A IL 15166701 A IL15166701 A IL 15166701A IL 151667 A0 IL151667 A0 IL 151667A0
Authority
IL
Israel
Prior art keywords
igg
igg fraction
iii
fraction
derived
Prior art date
Application number
IL15166701A
Other languages
English (en)
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20279068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL151667(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Publication of IL151667A0 publication Critical patent/IL151667A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15166701A 2000-03-30 2001-03-29 A METHOD OF PRODUCING IgG IL151667A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG
PCT/EP2001/003624 WO2001072844A2 (fr) 2000-03-30 2001-03-29 Procédé de production d'igg

Publications (1)

Publication Number Publication Date
IL151667A0 true IL151667A0 (en) 2003-04-10

Family

ID=20279068

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15166701A IL151667A0 (en) 2000-03-30 2001-03-29 A METHOD OF PRODUCING IgG

Country Status (15)

Country Link
US (1) US6835379B2 (fr)
EP (1) EP1268551B1 (fr)
JP (1) JP2003530326A (fr)
CN (1) CN1419566A (fr)
AT (1) ATE260297T1 (fr)
AU (2) AU2001273907B2 (fr)
BR (1) BRPI0109740B8 (fr)
CA (1) CA2402784A1 (fr)
DE (1) DE60102144T2 (fr)
IL (1) IL151667A0 (fr)
PT (1) PT1268551E (fr)
RU (1) RU2266914C2 (fr)
SE (1) SE0001128D0 (fr)
TR (1) TR200400701T4 (fr)
WO (1) WO2001072844A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451031C (zh) * 2003-09-05 2009-01-14 东丽株式会社 生物体成分组成改变了的溶液的调制方法
ATE540050T1 (de) * 2003-09-05 2012-01-15 Toray Industries Verfahren zur herstellung einer proteomanalyse- lösung
EP1532983A1 (fr) 2003-11-18 2005-05-25 ZLB Bioplasma AG Preparation d'immunoglobulines à stabilité élevée
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
CN100362022C (zh) * 2005-11-07 2008-01-16 中国人民解放军第二军医大学 海螵蛸多糖cps-1及其制备方法和用途
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
WO2007136327A1 (fr) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab Procédé de production d'igg
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
EA023382B1 (ru) 2009-05-27 2016-05-31 Бакстер Интернэшнл Инк. Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения
WO2011073235A1 (fr) 2009-12-18 2011-06-23 Csl Ltd. Procédé de purification de polypeptides
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (fr) 2010-02-26 2011-08-31 CSL Behring AG Préparation d'immunoglobuline et système de stockage pour préparation d'immunoglobuline
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
BR112014004445B1 (pt) * 2011-08-26 2022-11-22 Takeda Pharmaceutical Company Limited Método para reduzir conteúdo de fator xi e/ou fator xia em uma composição de imunoglobulina
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US8986670B2 (en) 2012-02-29 2015-03-24 Baxter International Inc. IgG stimulated remyelination of peripheral nerves
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
CN104231065A (zh) * 2014-09-09 2014-12-24 青岛康大食品有限公司 兔血中球蛋白的纯化制备方法
WO2017066683A1 (fr) 2015-10-15 2017-04-20 Plasma Technologies, Llc Procédés d'extraction de protéines à partir de plasma sanguin
CA3012694A1 (fr) * 2016-02-03 2017-08-10 Plasma Technologies, Llc Procedes d'extraction de proteines a partir d'un materiau a base de sang
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
MX2022011950A (es) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE59009020D1 (de) 1990-03-22 1995-06-08 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates.
DE4118912C1 (fr) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
ES2129076T5 (es) 1993-12-27 2003-05-16 Zlb Bioplasma Ag Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene.
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
KR100501263B1 (ko) * 1998-06-09 2005-07-18 스태튼스 세룸 인스티튜트 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren

Also Published As

Publication number Publication date
EP1268551A2 (fr) 2003-01-02
PT1268551E (pt) 2004-07-30
US20030143222A1 (en) 2003-07-31
DE60102144T2 (de) 2004-10-28
SE0001128D0 (sv) 2000-03-30
BR0109740A (pt) 2003-02-04
US6835379B2 (en) 2004-12-28
DE60102144D1 (de) 2004-04-01
RU2002124857A (ru) 2004-02-20
CN1419566A (zh) 2003-05-21
ATE260297T1 (de) 2004-03-15
AU7390701A (en) 2001-10-08
BRPI0109740B8 (pt) 2021-05-25
CA2402784A1 (fr) 2001-10-04
WO2001072844A2 (fr) 2001-10-04
JP2003530326A (ja) 2003-10-14
EP1268551B1 (fr) 2004-02-25
AU2001273907B2 (en) 2006-02-02
WO2001072844A3 (fr) 2002-04-11
TR200400701T4 (tr) 2004-05-21
RU2266914C2 (ru) 2005-12-27
BR0109740B1 (pt) 2015-01-06

Similar Documents

Publication Publication Date Title
IL151667A0 (en) A METHOD OF PRODUCING IgG
TW245768B (en) Method for killing microorganisms
JPH0231689A (ja) 百日咳トキシンの精製法
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
CA2557229A1 (fr) Procede de realisation d'une preparation anticorps avirale purifiee
MXPA06008435A (es) Proceso de manufactura de una inmunoglobulina libre de virus.
FR2737730B1 (fr) Procede de purification de virus par chromatographie
ATE163043T1 (de) Reinigungsmethode und entsprechende vorrichtung
ES2136115T3 (es) Enzima formadora de sacaridos no reductores, y su preparacion y usos.
PL347472A1 (en) Process for purifying human papillomavirus virus-like particles
FR2539629B1 (fr) Procede de production d'air sterile pour usage medical et installation pour la mise en oeuvre de ce procede
JPS5944320A (ja) Ｃ１不活性化剤の調製方法
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
CA2244095A1 (fr) Procede de production d'un catalyseur pour l'epuration des gaz d'echappement
SI9420008B (sl) Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje
WO2003034982A3 (fr) Procede de purification a rendement eleve d'immuno-globulines a partir de plasma sanguin et d'intermediaires de plasma sanguin
ES8505820A1 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
RU2006118024A (ru) Способ удаления вирусов из жидкой композиции, содержащей фактор vii
CN1181782A (zh) 一种从生物原料中制备因子ix的方法
AT381026B (de) Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
AU726808B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
AU2002359583A1 (en) An exhaust treatment and filtration system for molten carbonate fuel cells
EP1078911A3 (fr) Procédé de purification fine d'une solution aqueuse contenant un acide organique obtenu par fermentation
TWI526214B (zh) 缺乏一種以上致血栓因子的血漿製品之製備方法
JPS5758629A (en) Separating and purifying method of colonization stimulating factor and callicrein in human urine

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees